Authors
Aarti Krishnan, Hanqun Cao, James J Collins, Cesar de la Fuente-Nunez
Published in
Science translational medicine. Volume 18. Issue 871. Pages eaee4629. Oct 14, 2026. Epub Oct 14, 2026.
Abstract
Artificial intelligence (AI) now enables the exploration of vast chemical and sequence spaces, the design of synthesizable antibiotics, and the prioritization of safe, mechanism-diverse candidates through integrated modeling and accelerated testing. Here, we survey recent advances in AI for both small-molecule and peptide antimicrobial drugs, highlight emerging data and reporting standards, and outline translational pathways and regulatory hurdles needed to bring these agents to patients.
PMID:
42873898
Bibliographic data and abstract were imported from PubMed on 15 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0